Jacobio Pharmaceuticals Group Co., Ltd. (HK:1167) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Jacobio Pharmaceuticals Group Co., Ltd. will showcase clinical data for their BET inhibitor, JAB-8263, at the upcoming 66th American Society of Hematology Annual Meeting in December 2024. The company, which is dedicated to creating innovative health solutions across six major signaling pathways, cautions there is no guarantee of JAB-8263’s successful development or marketability.
For further insights into HK:1167 stock, check out TipRanks’ Stock Analysis page.